{"canonical":"https://abierto.us/opportunities/75f40124r00023","key":"75F40124R00023","url":"https://abierto.us/opportunities/75f40124r00023","title":"Post-Market Bioequivalence of Generic Drug Product","solicitation_number":"75F40124R00023","notice_type":"o","open":false,"response_deadline":"2024-01-24T15:00:00Z","first_posted":"2024-01-03","last_posted":"2024-01-03","department":"HEALTH AND HUMAN SERVICES, DEPARTMENT OF","subagency":"FOOD AND DRUG ADMINISTRATION","office":"FDA CENTER FOR DRUG EVALUATION AND RESEARCH","naics":"541715","psc":"B529","set_aside":"8A","place_state":null,"place_county":null,"place_county_name":null,"place_city":null,"place_city_name":null,"winner":null,"award_amount":null,"publications":[{"notice_id":"a061632886ee4a9db8436d9ca0b64491","title":"Post-Market Bioequivalence of Generic Drug Product","solicitation_number":"75F40124R00023","notice_type":"o","base_type":"o","posted":"2024-01-03","posted_at":null,"due_at":"2024-01-12T15:00:00Z","due_date":"2024-01-12","cancelled":null,"archived":null,"archive_date":"2024-01-27","award_number":null,"awardee_name":null,"amount":null,"link_sam":"https://sam.gov/workspace/contract/opp/a061632886ee4a9db8436d9ca0b64491/view","enriched":false,"history":[]},{"notice_id":"dd88a10420b4470e9f1af897fe438c04","title":"Post-Market Bioequivalence of Generic Drug Product","solicitation_number":"75F40124R00023","notice_type":"o","base_type":"o","posted":"2024-01-03","posted_at":null,"due_at":"2024-01-24T15:00:00Z","due_date":"2024-01-24","cancelled":null,"archived":null,"archive_date":"2024-02-08","award_number":null,"awardee_name":null,"amount":null,"link_sam":"https://sam.gov/workspace/contract/opp/dd88a10420b4470e9f1af897fe438c04/view","enriched":false,"history":[]}],"latest_notice_id":"dd88a10420b4470e9f1af897fe438c04","first_type":"o","notices":[{"dates":{"posted":"2024-01-03","response_deadline":{"raw":"2024-01-12T10:00:00-05:00","utc":"2024-01-12T15:00:00Z","date":"2024-01-12","time":"10:00:00","utc_offset_seconds":-18000}},"links":{"sam":"https://sam.gov/workspace/contract/opp/a061632886ee4a9db8436d9ca0b64491/view"},"naics":{"codes":["541715"],"primary":"541715"},"title":"Post-Market Bioequivalence of Generic Drug Product","agency":{"office":{"code":"75DKKN","name":"FDA CENTER FOR DRUG EVALUATION AND RESEARCH"},"subtier":{"code":"7524","name":"FOOD AND DRUG ADMINISTRATION"},"department":{"code":"075","name":"HEALTH AND HUMAN SERVICES, DEPARTMENT OF"},"office_address":{"zip":"20993","city":"Silver Spring","state":"MD","country":"USA"},"organization_type":"OFFICE"},"status":{"active":false,"archive_date":"2024-01-27","archive_type":"auto15"},"contacts":[{"name":"Telisha WIlson","role":"primary","email":"telisha.wilson@fda.hhs.gov"}],"base_type":{"code":"o","label":"Solicitation"},"notice_id":"a061632886ee4a9db8436d9ca0b64491","set_aside":{"code":"8A","label":"8(a) Set-Aside (FAR 19.8)"},"provenance":{"extract":{"url":"https://s3.amazonaws.com/falextracts/Contract%20Opportunities/Archived%20Data/FY2024_archived_opportunities.csv","etag":"\"d582488fe153a9f11bf629913d176ffc-137\"","fetched_at":"2026-09-16T19:07:39.720164Z","row_sha256":"a86e81eaf93931f2d315b5fda01924ba1b106261a5c4b9fe4de9f47d6884d2c0","last_modified":"2026-09-13T14:47:40Z"},"updated_at":"2026-09-16T19:07:39.720164Z","first_seen_at":"2026-09-16T19:07:39.720164Z"},"description":{"text":"Post-Market Bioequivalence of Generic Drug Product Questions are due 10AM EST 12/22/2023 Proposals are due 10AM EST 01/12/2024","origin":"extract"},"notice_type":{"code":"o","label":"Solicitation"},"schema_version":1,"solicitation_number":"75F40124R00023","product_service_code":"B529"},{"dates":{"posted":"2024-01-03","response_deadline":{"raw":"2024-01-24T10:00:00-05:00","utc":"2024-01-24T15:00:00Z","date":"2024-01-24","time":"10:00:00","utc_offset_seconds":-18000}},"links":{"sam":"https://sam.gov/workspace/contract/opp/dd88a10420b4470e9f1af897fe438c04/view"},"naics":{"codes":["541715"],"primary":"541715"},"title":"Post-Market Bioequivalence of Generic Drug Product","agency":{"office":{"code":"75DKKN","name":"FDA CENTER FOR DRUG EVALUATION AND RESEARCH"},"subtier":{"code":"7524","name":"FOOD AND DRUG ADMINISTRATION"},"department":{"code":"075","name":"HEALTH AND HUMAN SERVICES, DEPARTMENT OF"},"office_address":{"zip":"20993","city":"Silver Spring","state":"MD","country":"USA"},"organization_type":"OFFICE"},"status":{"active":false,"archive_date":"2024-02-08","archive_type":"auto15"},"contacts":[{"name":"Telisha WIlson","role":"primary","email":"telisha.wilson@fda.hhs.gov"}],"base_type":{"code":"o","label":"Solicitation"},"notice_id":"dd88a10420b4470e9f1af897fe438c04","set_aside":{"code":"8A","label":"8(a) Set-Aside (FAR 19.8)"},"provenance":{"extract":{"url":"https://s3.amazonaws.com/falextracts/Contract%20Opportunities/Archived%20Data/FY2024_archived_opportunities.csv","etag":"\"d582488fe153a9f11bf629913d176ffc-137\"","fetched_at":"2026-09-16T19:07:39.720164Z","row_sha256":"72e17d00d01add16d9e9234a9a575805045ab22b9093ac365a872250d9c1cd34","last_modified":"2026-09-13T14:47:40Z"},"updated_at":"2026-09-16T19:07:39.720164Z","first_seen_at":"2026-09-16T19:07:39.720164Z"},"description":{"text":"Post-Market Bioequivalence of Generic Drug Product 01/03/2024- Amendment to provide the government's response to quesions and to provide a new proposal due date. Proposals are due 10AM EST 01/24/2024","origin":"extract"},"notice_type":{"code":"o","label":"Solicitation"},"schema_version":1,"solicitation_number":"75F40124R00023","product_service_code":"B529"}],"due_at":"2024-01-24T15:00:00Z","due_date":"2024-01-24","closes_at":"2024-01-24T15:00:00Z","awardable":true,"dept_key":"d-075","dept_name":"HEALTH AND HUMAN SERVICES, DEPARTMENT OF","sub_key":"s-7524","sub_name":"FOOD AND DRUG ADMINISTRATION","office_key":"o-75DKKN","office_name":"FDA CENTER FOR DRUG EVALUATION AND RESEARCH","state":null,"county":null,"county_name":null,"city":null,"city_name":null,"country":null,"winner_key":null,"amount":null,"linked_awards":0,"cancelled":false,"archived":false,"updated_at":"2026-09-16T21:18:12.857524Z","principal_notice_id":"dd88a10420b4470e9f1af897fe438c04","description":{"text":"Post-Market Bioequivalence of Generic Drug Product 01/03/2024- Amendment to provide the government's response to quesions and to provide a new proposal due date. Proposals are due 10AM EST 01/24/2024","html":null,"origin":"extract"},"contacts":[{"name":"Telisha WIlson","role":"primary","email":"telisha.wilson@fda.hhs.gov"}],"place_of_performance":null,"office_address":{"zip":"20993","city":"Silver Spring","state":"MD","country":"USA"},"naics_codes":["541715"],"award":null,"attachments":[],"awards":[],"related":[]}